Alexion Pharmaceuticals, Inc.
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Alexion Pharmaceuticals, Inc.
- Company name
- Alexion Pharmaceuticals, Inc.
- Organisation type
- Industry
- Registered legal name
- Alexion Pharmaceuticals, Inc.
- Registry sponsor category
- Industry
- Website
- https://alexion.com/
- Legal Entity Identifier (LEI)
- M1YXUUZR0EIMU8T0EM75
- Wikidata ID
- Q204727
Related records
Trials (291)
- A Drug Interaction Study Between Danicopan and Midazolam, Fexofenadine, and Mycophenolate Mofetil in Healthy Participants
- A Drug Interaction Study of ACH-0145228
- A Drug Interaction Study of Danicopan
- A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH
- A Long-Term Treatment Study of ACH-0144471 in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- A Open Label Study in Previously Studied, SBC-103 Treatment Naïve MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
- A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- A Phase 2A Study of ALXN1007 in Participants With Newly Diagnosed Acute Lower Gastrointestinal Graft-Versus-Host Disease
- A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)
- A Phase 3 Study of ALXN2060 in Japanese Participants With Symptomatic ATTR-CM
- A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471
- A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G)
- A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN
- A Prospective Sub-Study of the Global Hypophosphatasia Registry
- A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
- A Retrospective Chart Review of Deceased Patients With Mucopolysaccharidosis Type IIIB
- A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype
- A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)
- A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
- A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)